Joshua J Neumiller1, David A Sclar2, Linda M Robison3, Stephen M Setter1, Tracy L Skaer2. 1. Department of Pharmacotherapy, College of Pharmacy, Washington State University, Spokane, Washington. 2. Department of Pharmacotherapy, Department of Health Policy and Administration, College of Pharmacy, Washington State University, Pullman, Washington. 3. Department of Health Policy and Administration, College of Pharmacy, Washington State University, Pullman, Washington.
Abstract
BACKGROUND: Persons with diabetes mellitus (DM) exhibit a higher rate of depressive illness than does the general US population. Despite this finding, previous research has documented a low rate of diagnosis and/or treatment with antidepressant pharmacotherapy among persons with DM. OBJECTIVE: The aim of this study was to examine the current rate of diagnosis of depression and use of antidepressant pharmacotherapy among persons with DM. RESULTS: We examined data from the 2005 US National Ambulatory Medical Care Survey. In 2005, there were an estimated 35,345,845 persons with an office-based visit for DM and, of these, 3,823,508 (10.8%) had a concomitant diagnosis of depression. Within this subset, 1,830,620 (47.9%) were prescribed antidepressant pharmacotherapy. CONCLUSION: Our findings serve to quantify the prevalence of a diagnosis of depression and use of antidepressant pharmacotherapy for its treatment among persons with DM in the United States.
BACKGROUND:Persons with diabetes mellitus (DM) exhibit a higher rate of depressive illness than does the general US population. Despite this finding, previous research has documented a low rate of diagnosis and/or treatment with antidepressant pharmacotherapy among persons with DM. OBJECTIVE: The aim of this study was to examine the current rate of diagnosis of depression and use of antidepressant pharmacotherapy among persons with DM. RESULTS: We examined data from the 2005 US National Ambulatory Medical Care Survey. In 2005, there were an estimated 35,345,845 persons with an office-based visit for DM and, of these, 3,823,508 (10.8%) had a concomitant diagnosis of depression. Within this subset, 1,830,620 (47.9%) were prescribed antidepressant pharmacotherapy. CONCLUSION: Our findings serve to quantify the prevalence of a diagnosis of depression and use of antidepressant pharmacotherapy for its treatment among persons with DM in the United States.
Authors: K M Venkat Narayan; James P Boyle; Linda S Geiss; Jinan B Saaddine; Theodore J Thompson Journal: Diabetes Care Date: 2006-09 Impact factor: 19.112
Authors: J P Boyle; A A Honeycutt; K M Narayan; T J Hoerger; L S Geiss; H Chen; T J Thompson Journal: Diabetes Care Date: 2001-11 Impact factor: 19.112
Authors: Richard R Rubin; Yong Ma; David G Marrero; Mark Peyrot; Elizabeth L Barrett-Connor; Steven E Kahn; Steven M Haffner; David W Price; William C Knowler Journal: Diabetes Care Date: 2007-12-10 Impact factor: 19.112